The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Improving prostate cancer risk stratification using spatial single-cell tumor profiling.
 
William Chen
No Relationships to Disclose
 
Mikhail Dias
No Relationships to Disclose
 
Chien-Kuang Ding
Research Funding - Bristol Myers Squibb Foundation (Inst); Intuitive Surgical (Inst)
 
Stefanie Engler
No Relationships to Disclose
 
Sophie Déglise
No Relationships to Disclose
 
Aishwarya Subramanian
No Relationships to Disclose
 
Haolong Li
No Relationships to Disclose
 
Andrea Jacobs
Employment - Navignostics
Leadership - Navignostics
Stock and Other Ownership Interests - Navignostics
 
Martin Sjöström
Honoraria - Astellas Pharma
Consulting or Advisory Role - Adelphi Targis; Veracyte
Research Funding - PFS Genomics (Inst); PFS Genomics (Inst)
 
Jonathan Chou
Consulting or Advisory Role - Exai Bio
Research Funding - Amgen (Inst)
 
Julian Hong
Research Funding - Roche (Inst)
 
Shuang Zhao
Employment - Artera (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Patents, Royalties, Other Intellectual Property - Patent applications pending (Inst); Patent applications pending licensed to Veracyte (Inst)
 
Jeffry Simko
No Relationships to Disclose
 
Eric Small
Stock and Other Ownership Interests - Fortis; Teon Therapeutics
 
Alan Ashworth
Leadership - Cambridge Science Corporation; CytomX Therapeutics
Stock and Other Ownership Interests - Ambagon Therapeutics; Azkarra Therapeutics; Bluestar Genomics; Circle Pharma; Earli; Gladiator Biosciences; Kytarro; Novartis; OVIBIO; Phoenix Molecular Designs; Prolynx; ProLynx; Tango Therapeutics; Trial Library; Trial Library; Yingli Pharma
Consulting or Advisory Role - Ambagon Therapeutics; Azkarra Therapeutics; Bluestar Genomics; Circle Pharma; Genentech; Gladiator Biosciences; GlaxoSmithKline; Kytarro; OVIBIO; Phoenix Molecular Designs; Tango Therapeutics; Yingli Pharma
 
David Quigley
No Relationships to Disclose
 
Peter Carroll
Stock and Other Ownership Interests - Nutcracker Therapeutics, Inc.; Nutcracker Therapeutics, Inc.
Honoraria - BIOPHARM; Exact Sciences
Consulting or Advisory Role - Alessa Therapeutics; Francis Medical; Insightec; Johnson & Johnson/Janssen; Progenics
Research Funding - Intuitive Surgical (Inst); Progenics (Inst)
 
Matthew Cooperberg
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; LynxDx; Merck; Pfizer; Tempus; Veracyte; Verana Health
 
Bernd Bodenmiller
Leadership - Navignostics
Stock and Other Ownership Interests - Navignostics
Consulting or Advisory Role - Navignostics
 
Felix Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics